Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxicyllin and either clarithromycin or azithromycin

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 997-1000

  Cammarota, G ^a   Tursi, A ^a   Papa, A ^a   Montalto, M ^a   Veneto, G ^a   Cuoco, L ^a   Fedeli, G ^a   Gasbarrini, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLARITHROMYCIN; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0029850831     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.d01-533.x     Document Type: Article

References (18)

1. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
2. Buiatti E, Munoz N, Vivas J, et al. Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes Control 1994; 5: 249-54.
3. Bazzoli F, Zagari RM, Fossi S. et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
4. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor and its related compounds have selectivity activity against Helicobacter pylori. Antimicrob Agents Chemother 1991: 35: 490-6.
5. Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 337: 1486.
6. Shimada T, Ogura K, Ota S, Terano A. Clinical efficacy of lansoprazole-amoxycillin treatment in eradicating Helicobacter pylori: evaluation by Polymerase Chain Reaction. J Clin Gastroenterol 1995; 20 (Suppl. 2): S100-3.
7. Shimoyama T, Munakata I, Mizuki I, et al. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. J Clin Gastroenterol 1995; 20 (Suppl. 2): S125-7.
8. Harris AW, Gummett PA, Logan RPH, et al. Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Aliment Pharmacol Ther 1995; 9: 201-4.
9. Lamouliatte H, Cayala R, Forestier S, et al. Dual therapy versus triple therapy: high dose of lansoprazole plus amoxycillin in combination or not with clarithromycin for Helicobacter pylori infection. Gut 1995; 37 (Suppl. 1): A92.
10. Tursi A, Cammarota G, Montalto M. et al. The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 817-8. (Letter.)
11. Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1-3.
12. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. The MACH1 study: optimal one-week treatment for H. pylori defined? Gut 1995; 37 (Suppl. 1): A4. (Abstract.)
13. Tursi A, Cammarota G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 285-8.
14. Labenz J, Stolte M, Peitz U, et al. One-week triple therapy with omeprazole, amoxycillin and either clarthromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 207-10.
15. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain C. Effects of antibiotic-resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995; 37 (Suppl. 1): A55. (Abstract.)
16. Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H. Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995; 37 (Suppl. 1): A55. (Abstract.)
17. Hardy DJ, Hanson CW, Hensey DM, et al. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother 1988; 22: 631-6.
18. Glupczynski Y, Burette A. Failure of azithromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. Am J Gastroenterol 1990; 85: 98-9. (Letter.)